Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy. [electronic resource]
Producer: 20140714Description: 225-31 p. digitalISSN:- 2038-2529
- Aged
- Aged, 80 and over
- Anemia -- blood
- Antineoplastic Agents -- administration & dosage
- Darbepoetin alfa
- Drug Administration Schedule
- Erythropoietin -- administration & dosage
- Fatigue -- etiology
- Female
- Follow-Up Studies
- Hematinics -- administration & dosage
- Hemoglobins -- metabolism
- Humans
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Prospective Studies
- Quality of Life
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.